Transplantation: Immunosuppression and risk of polyomavirus BK replication

Nature Reviews Nephrology

Volumn 9, Issue 3, 2013, Pages 135-136

  Pham, Phuong Thu T ^a   Reddy, Uttam G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; CALCINEURIN INHIBITOR; CYCLOSPORIN A; CYTOCHROME P450 3A; MYCOPHENOLIC ACID; PREDNISONE; TACROLIMUS;

BK VIRUS; DRUG BIOAVAILABILITY; DRUG EXPOSURE; GRAFT RECIPIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; ORGAN DONOR; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; VIRUS REPLICATION;

BK VIRUS; CYCLOSPORINE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; POLYOMAVIRUS INFECTIONS; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; TACROLIMUS; TUMOR VIRUS INFECTIONS; VIREMIA; VIRUS REPLICATION;

EID: 84874655631     PISSN: 17595061     EISSN: 1759507X     Source Type: Journal    
DOI: 10.1038/nrneph.2013.17     Document Type: Review

References (10)

1. Schold, J. D. et al. Treatment for BK virus: incidence, risk factors and outcomes for kidney transplant recipients in the United States. Transpl. Int. 22, 626-634 (2009).
2. Bohl, D. L. et al. Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia. Am. J. Transplant. 5, 2213-2221 (2005).
3. Hirsch, H. H. et al. Polyomavirus BK replication in de novo kidney transplant patients receiving tacrolimus or cysclosporine: a prospective, randomized, multicenter study. Am. J. Transplant. http://dx.doi.org/10.1111/j. 1600-61432012.04320.x.
4. Binet, I. et al. Polyomavirus disease under new immunosuppressive drugs: a cause of renal graft dysfunction and graft loss. Transplantation 67, 918-922 (1999).
5. Manitpisitkul, W. et al. Maintenance immunosuppressive agents as risk factors for BK virus nephropathy: a case-control study. Transplantation 88, 83-88 (2009).
6. Hardinger, K. L., Koch, M. J., Bohl, D. J., Storch, G. A. & Brennan, D. C. BK-virus and the impact of pre-emptive immunosuppression reduction: 5-year results. Am. J. Transplant. 10, 409-415 (2010).
7. Anglicheau, D. et al. Pharmacokinetic interaction between corticosteroids and tacrolimus after renal transplantation. Nephrol. Dial. Transplant. 18, 2409-2414 (2003).
8. Vincenti, F. et al. Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. Am. J. Transplant. 7, 1506-1514 (2007).
9. Acott, P. D., O'Regan, P. A., Lee, H. S. & Crocker, J. F. In vitro effect of cyclosporine A on primary and chronic BK polyoma virus infection in Vero E6 cells. Transpl. Infect. Dis. 10, 385-390 (2008).
10. Pham, P.-T., Schaenman, J. & Pham, P. C. BK virus screening and management following kidney transplantation: an update. J. Transplant. Technol. Res. 2, e119 (2012).